Austria vs Belgium: Proportion of isolates with decreased susceptibility or resistance
Austria
0
in 2020
Belgium
0.6
in 2020
Austria rank
13th
Belgium rank
10th
Proportion of isolates with decreased susceptibility or resistance over time
- Austria
- Belgium
How they compare
Belgium currently reports 0.6 against 0 in Austria, a difference of 0.6.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was Belgium ahead.
Austria ranks 13th and Belgium ranks 10th of 52 countries.
Across the 3 decades both report, Austria averaged higher in 1 and Belgium in 1.
Head to head by decade
| Decade | Austria | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0.3538 | 0 | 0.3538 | Austria |
| 2020s | 0 | 0.6 | 0.6 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Austria or Belgium?
- Belgium, at 0.6 against 0 in Austria as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Austria and Belgium?
- 0.6, with Belgium ahead.
- How many years of comparable data are there for Austria and Belgium?
- 10 years are reported by both, from 2009 to 2020.
- How do Austria and Belgium rank globally for proportion of isolates with decreased susceptibility or resistance?
- Austria ranks 13th and Belgium ranks 10th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.